IntelliAM aiming for significant growth with £5 million Aquis IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJPM.L Regulatory News (JPM)

  • There is currently no data for JPM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

18 Jul 2008 17:18

RNS Number : 4556Z
JPMorgan US Discovery IT PLC
18 July 2008
 



Form TR-1 with annex. FSA Version 2.1 updated April 2007

For filings with the FSA include the annex

For filings with issuer exclude the annex 

TR-1: Notifications of Major Interests in Shares

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

JPMorgan US Discovery Investment Trust Plc

2. Reason for notification (yes/no)

An acquisition or disposal of voting rights

An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached 

An event changing the breakdown of voting rights

Other (please specify):  Change to Issued Share Capital

YES

3. Full name of person(s) subject to notification obligation:

JPMorgan Chase & Co

4. Full name of shareholder(s) (if different from 3):

JPMorgan Asset Management (UK) Limited

5. Date of transaction (and date on which the threshold is crossed or reached if different):

30 June 2008

6. Date on which issuer notified:

18 July 2008

7. Threshold(s) that is/are crossed or reached:

14%

8: Notified Details

A: Voting rights attached to shares

Class/type of shares

If possible use ISIN code

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of shares

Number of voting rights

Number of shares

Number of voting rights

Percentage of voting rights

Direct

Indirect

Direct

Indirect

GB0003417101 

892,386

892,386

892,386

892,386

14.06%

B: Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date

Exercise/ conversion period/date 

No. of voting rights that may be acquired (if the instrument exercised/converted)

Percentage of voting rights

N/A

Total (A+B)

Number of voting rights

Percentage of voting rights

892,386

14.06%

9. Chain of controlled undertakings through which the voting rights and /or the financial instruments are effectively held, if applicable:

Total disclosable holding for JPMorgan Chase & Co. : 892,386 (14.06%)

Holdings by controlled undertakings of JPMorgan Chase & Co. are as follows:

JPMorgan Asset Management (UK) Limited892,386 (14.06%)

Proxy Voting:

10. Name of proxy holder:

N/A

11. Number of voting rights proxy holder will cease to hold:

N/A

12. Date on which proxy holder will cease to hold voting rights:

N/A

13. Additional information:

Please note the group has other holdings which are covered by exemptions.

14 Contact name:

Tracey Young

15. Contact telephone name:

020 7325 4513

For notes on how to complete form TR-1 please see the FSA website.   

Note: Annex should only be submitted to the FSA not the issuer

Annex: Notification of major interests in shares

A: Identity of the persons or legal entity subject to the notification obligation

Full name 

(including legal form of legal entities)

JPMorgan Chase & Co

Contact address 

(registered office for legal entities)

270 Park AvenueNew York, NY10017

Phone number & email

001 212 270 6000

Other useful information 

(at least legal representative for legal persons)

N/A

B: Identity of the notifier, if applicable

Full name

Tracey Young

Contact address

JPMorgan Chase Bank, N.A., 13th Floor, 125 London Wall, LondonEC2Y 5AJ

Phone number & email

020 7325 4513

tracey.l.young@jpmorgan.com

Other useful information

(e.g. functional relationship with the person or legal entity subject to the notification obligation)

N/A

C: Additional information

N/A

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLRPMFTMMBBBFP
Date   Source Headline
20th Nov 20137:00 amBUSJPMorgan Chase Reaches Settlement with the President’s Task Force on Residential Mortgage-Backed Securities
18th Nov 20137:00 amBUSJPMorgan Chase Reaches an Agreement with 21 Institutional Investors to Resolve Repurchase and Servicing Claims
4th Nov 20136:19 pmRNSPublication of Supplementary Prospectus
1st Nov 201312:28 pmRNSJPMC&Co. Form 10-Q (3Q 2013)
28th Oct 20137:00 amBUSJPMorgan Chase Reaches Settlements with the Federal Housing Finance Agency, Freddie Mac and Fannie Mae
22nd Oct 20131:09 pmRNSPublication of Final Terms
22nd Oct 201310:14 amRNSHolding(s) in Company
21st Oct 20132:53 pmBUSJPMorgan Chase to Present at the Goldman Sachs Financial Services Conference
15th Oct 20135:08 pmRNSPublication of Supplementary Prospectus
14th Oct 20136:02 pmBUSJPMorgan Chase Declares Preferred Stock Dividend
11th Oct 20132:13 pmRNSForm 8-K dated October 11, 2013
11th Oct 201312:03 pmBUSJPMorgan Chase Reports Third-Quarter 2013 Net Loss of $0.4 Billion, or $(0.17) Per Share, on Revenue1 of $23.9 Billion
8th Oct 201312:30 pmBUSJPMorgan Chase Names Dana Deasy Chief Information Officer
7th Oct 20132:30 pmBUSJPMorgan Chase to Present at the Bank of America Merrill Lynch 2013 Banking and Financial Services Conference
2nd Oct 20132:03 pmBUSJPMorgan Chase & Co. Names Bruce McNamer Head of Global Philanthropy and CEO of the JPMorgan Chase Foundation
2nd Oct 20132:00 pmBUSJPMorgan Chase to Present at the BancAnalysts Association of Boston Conference
1st Oct 20133:18 pmBUSChase to Award $3 Million to Small Businesses Through Mission Main StreetSM Grants; Premier Sponsor Google Provides Special Advertising Offer
25th Sep 20137:20 amRNSNOTIFICATION OF INTEREST IN SHARES
24th Sep 20131:12 pmRNSPublication of Prospectus
23rd Sep 20137:00 amBUSNew Investment Fund Will Advance Late-Stage Vaccines and other Global Health Technologies
19th Sep 20132:41 pmRNSForm 8-K dated September 19, 2013
19th Sep 20132:32 pmBUSJPMorgan Chase reaches settlements with SEC, FCA, OCC and Federal Reserve on CIO trading matter
18th Sep 20135:23 pmRNSDividend Declaration
18th Sep 20137:00 amBUSJPMorgan Chase Declares Common Stock Dividend
17th Sep 20137:00 amBUSJPMorgan Chase Announces Dodd-Frank Mid-Year Stress Test Results
16th Sep 20136:06 pmBUSJPMorgan Chase Continues Code for Good Challenges in the U.S.
16th Sep 20137:00 amBUSJPMorgan Chase Declares Preferred Stock Dividends
13th Sep 20133:48 pmRNSHolding(s) in Company
13th Sep 20139:40 amRNSHolding(s) in Company
9th Sep 20132:00 pmBUSJPMorgan Chase to Elect Linda Bammann and Michael Neal to Its Board of Directors
4th Sep 20133:45 pmRNSHolding(s) in Company
23rd Aug 20137:00 amRNSHolding(s) in Company
19th Aug 20137:00 amBUSJPMorgan Chase Announces Conference Call to Review Third Quarter 2013 Earnings
14th Aug 20134:37 pmRNSAnnouncement
9th Aug 20137:00 amRNSPublication of Supplementary Prospectus
8th Aug 20134:05 pmBUSJPMorgan Chase to Present at the Barclays Global Financial Services Conference
8th Aug 20137:00 amRNSJPMC&Co. Form 10-Q (2Q 2013)
2nd Aug 20137:00 amBUSJPMorgan Chase to Redeem All $1.8 Billion of Its 8.625% Non-Cumulative Preferred Stock, Series J Represented by Depositary Shares
19th Jul 20134:30 pmBUSJPMorgan Chase Announces Retirement of Two Directors from Its Board
15th Jul 20136:15 pmBUSJPMorgan Chase Declares Preferred Stock Dividend
15th Jul 20134:20 pmRNSPublication of Supplementary Prospectus
12th Jul 20132:25 pmRNSForm 8-K dated July 12, 2013
12th Jul 201312:09 pmBUSJPMorgan Chase Reports Second-Quarter 2013 Net Income of $6.5 Billion, or $1.60 Per Share, on Revenue1 of $26.0 Billion
29th May 20135:58 pmRNSPublication of Final Terms
28th May 20134:21 pmRNSJPMC&Co. Form 8-K dated May 23, 2013
23rd May 20132:41 pmRNSPublication of Final Terms
23rd May 20132:30 pmBUSBarry Sommers Named CEO of the Consumer Bank at Chase
22nd May 20137:00 amRNSJPMC&Co. press release dated May 21, 2013
17th May 20133:51 pmBUSJPMorgan Chase Announces Conference Call to Review Second Quarter 2013 Earnings
17th May 20132:40 pmBUSJPMorgan Chase Annual Meeting of Shareholders

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.